Literature DB >> 21635199

Fatigue in Parkinson's disease.

Joseph H Friedman1, Ana Abrantes, Lawrence H Sweet.   

Abstract

INTRODUCTION: Non-motor symptoms of Parkinson's disease (PD) have become increasingly recognized as central to the disease. These include somatic symptoms, such as pain and autonomic dysfunction (bladder dysfunction, constipation, dipahoresis and orthostatic hypotension) and behavioral problems, such as dementia, depression, fatigue, sleep disorders and psychosis. Research on fatigue has focused on its epidemiology with only a single report of a beneficial treatment trial, which used methylphenidate. AREAS COVERED: This review was made of all articles related to fatigue in Parkinson's disease arising in PUBMED. It will cover the types of fatigue, epidemiology, pathophysiology and treatment of fatigue in PD. EXPERT OPINION: Fatigue is a common and severe problem in Parkinson's disease. Virtually nothing is known about it aside from its epidemiology. It is an area greatly in need of investigation.

Entities:  

Mesh:

Year:  2011        PMID: 21635199     DOI: 10.1517/14656566.2011.587120

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  20 in total

1.  Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease.

Authors:  Matej Skorvanek; Iveta Nagyova; Jaroslav Rosenberger; Martina Krokavcova; Radka Ghorbani Saeedian; Johan W Groothoff; Zuzana Gdovinova; Jitse P van Dijk
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

2.  Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease.

Authors:  Andrzej Dekundy; Flora Mela; Martine Hofmann; Wojciech Danysz
Journal:  J Neural Transm (Vienna)       Date:  2014-10-16       Impact factor: 3.575

3.  The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients.

Authors:  Ioannis E Dagklis; Efthymia Tsantaki; Dimitrios Kazis; Varvara Theodoridou; Sotirios Papagiannopoulos; Dimitrios Ntantos; Sevasti Bostantjopoulou
Journal:  Neurol Sci       Date:  2019-01-08       Impact factor: 3.307

4.  Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson's Disease.

Authors:  Wanting Liu; Jianghong Liu; Rupal Bhavsar; Tianxin Mao; Eugenia Mamikonyan; David Raizen; John A Detre; Daniel Weintraub; Hengyi Rao
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

5.  Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.

Authors:  Sang Soo Cho; Kelly Aminian; Crystal Li; Anthony E Lang; Sylvain Houle; Antonio P Strafella
Journal:  Hum Brain Mapp       Date:  2016-08-29       Impact factor: 5.038

6.  Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Alberto R M Martinez; Marcelo B Nunes; Ingrid Faber; Anelyssa D'Abreu; Íscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2017-02       Impact factor: 3.847

7.  Modulatory effect of subthalamic nucleus on the development of fatigue during exhausting exercise: an in vivo electrophysiological and microdialysis study in rats.

Authors:  Dalei Wang; Xiaoli Liu; Decai Qiao
Journal:  J Sports Sci Med       Date:  2012-06-01       Impact factor: 2.988

8.  The use of the mini-mental state examination and the clock-drawing test for dementia in a tertiary hospital.

Authors:  Khaled Sallam; Mostafa Amr
Journal:  J Clin Diagn Res       Date:  2013-03-01

Review 9.  Interventions for fatigue in Parkinson's disease.

Authors:  Roy G Elbers; John Verhoef; Erwin Eh van Wegen; Henk W Berendse; Gert Kwakkel
Journal:  Cochrane Database Syst Rev       Date:  2015-10-08

10.  Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting.

Authors:  Ergun Y Uc; Kevin C Doerschug; Vincent Magnotta; Jeffrey D Dawson; Teri R Thomsen; Joel N Kline; Matthew Rizzo; Sara R Newman; Sonya Mehta; Thomas J Grabowski; Joel Bruss; Derek R Blanchette; Steven W Anderson; Michelle W Voss; Arthur F Kramer; Warren G Darling
Journal:  Neurology       Date:  2014-07-02       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.